Colliding gastric and intestinal phenotype well-differentiated adenocarcinoma of the stomach developing in an area of MALT-type lymphoma

Gastric Cancer

Volumn 6, Issue 4, 2003, Pages 270-276

  Suenaga, Mitsukuni ^a   Ohta, Kei Ichiro ^a   Toguchi, Masataka ^a   Sato, Takahiro ^a   Ohyama, Shigekazu ^a   Yamaguchi, Toshiharu ^a   Muto, Tetsuichiro ^a   Yanagisawa, Akio ^b   Kato, Yo ^b  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

Gastric carcinoma; Gastric phenotype adenocarcinoma; MALT type lymphoma

Indexed keywords

PROTEIN BCL 10;

AGED; ARTICLE; ATOMIC BOMB SURVIVOR; CANCER STAGING; CASE REPORT; CELL DIFFERENTIATION; FROZEN SECTION; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHOMA; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PARTIAL GASTRECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH TUMOR;

ADENOCARCINOMA; AGED; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PHENOTYPE; STOMACH NEOPLASMS;

EID: 0942266073     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-003-0260-5     Document Type: Article

References (30)

1. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 13th ed. Tokyo: Kanehara; 1999. pp. 4-6.
2. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearance. Gann 1968;59:251-8.
3. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
4. Egashira Y, Shimoda T, Ikegami M. Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 1999; 49:55-61.
5. Kushima R, Stolte M, Dirks K, Vieth M, Okabe H, Borchard F, et al. Gastric-type adenocarcinoma of the duodenal second portion histogenetically associated with hyperplasia and gastric-foveolar metaplasia of Brunner's glands. Virchows Arch 2002;440:655-9.
6. Hattori T, Kushima R. Gastric differentiated stomach adenocarcinoma; review (in German). Pathologe 2001;22:97-104.
7. Kabashima A, Yao T, Sugimachi K, Tsuneyoshi M. Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas. Histopathology 2000;37:513-22.
8. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000;89:724-32.
9. Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunochemistry and mucin histochemistry. Acta Pathol Jpn 1990;40:494-504.
10. Kushima R, Hattori T. Histogenesis and characteristics of gastric-type adenocarcinoma in the stomach. J Cancer Res Clin Oncol 1993;120:103-11.
11. Shimoda T, Fujisaki J, Kashimura H, Ikegami M, Ishii T, Matsui T, et al. Histological type of gastric carcinoma in relation to the mode of intramural spreading of cancer cells (in Japanese). Stomach and Intestine 1991;26:1125-34.
12. Kiyoko K, Yanagisawa A, Ninomiya Y, Inoshita N, Kato Y. Characteristics of differentiated-type carcinoma with gastric phenotype of the stomach (in Japanese). Stomach and Intestine 1999; 34:487-94.
13. Koseki K, Takizawa T, Koike M, Funata N, Hishima T, Hakuma T, et al. Subclassification of well differentiated gastric cancer with reference to biological behavior and malignancy, gastric type vs intestinal type, and papillary carcinoma vs tubular carcinoma (in Japanese). Stomach and Intestine 1999;34:507-12.
14. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer 1983;52:1410-6.
15. Isaacson P, Wright DH. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984;53:2515-24.
16. Ito C, Kato M, Yamamoto T, Ota N, Okuhara T, Mabuchi K, et al. Study of stomach cancer in atomic bomb survivors. Report of histological findings and prognosis. J Radiat Res 1989;30:164-75.
17. Kanamoto K, Aoyagi K, Nakamura S, Hizawa K, Suekane H, Sakamoto K, et al. Simultaneous coexistence of early adenocarcinoma and low-grade MALT lymphoma of the stomach associated with Helicobacter pylori infection: a case report. Gastrointest Endosc 1998;47:73-5.
18. Mochizuki Y, Makino T, Yamazaki Y, Suda T, Takemura H, Nakamura N. Synchronous gastric adenocarcinoma and MALT-type lymphoma with Helicobacter pylori infection. A case report (in Japanese). Jpn J Gastroenterol Surg 2000;33:605-9.
19. Sakatoku M, Ietsugu K, Nakashima H, Kiyohara K, Kosugi M, Terahata S. A case of early gastric endocrine cell carcinoma, gastric lymphoma and early gastric cancer (in Japanese). Nippon Rinshogeka Gakkai Zasshi (J Jpn Surg Assoc) 2001;62:2913-17.
20. Takahashi H, Tomita T, Hayakawa H. Synchronous early gastric adenocarcinoma and MALT-lymphoma with Helicobacter pylori infection (in Japanese). A case report. Jpn J Gastroenterol Surg 2001;34:571-5.
21. Kato Y, Aizu K, Barreto RZ, Maruyama M. The relationship between H. pylori infection, intestinal metaplasia and gastric cancer development. In: Kimura K, Sakaki N, editors. Helicobacter pylori and gastritis and gastric cancer (in Japanese). Tokyo: Igaku-shoin; 1996. pp. 208-14.
22. Sipponen P. Gastric cancer: pathogenesis, risk, and prevention. J Gastroenterol 2002;37 (Suppl 13):39-44.
23. Sipponen P, Kimura K. Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time. Eur J Gastroenterol Hepatol 1994;6 (Suppl 1):79-83.
24. Iwasaki K, Kawamoto K, Shimokawa I, Matsuo T, Ikeda T. Epidemiological studies on gastric cancer in Nagasaki (in Japanese). Gan No Rinsho (Clin Med Cancer) 1984;30:1746-54.
25. Suehiro S, Nagasue N, Abe S, Ogawa Y, Sasaki Y. Carcinoma of the stomach in atomic bomb survivors. A comparison of clinicopathologic features to the general population. Cancer 1986;57:1894-8.
26. Kai M, Leubeck EG, Moolgavkar SH. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis. Radiat Res 1997;148:348-58.
27. Little MP, Muirhead CR, Charles MW. Describing time and age variations in the risk of radiation-induced solid tumour incidence in the Japanese atomic bomb survivors using generalized relative and absolute risk models. Stat Med 1999;18:17-33.
28. Maea B, Demunter A, Peeters B, De Wolf-Peeters C. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MALT fusion is associated with aberrant nuclear BCL10 expression. Blood 2002;99:1398-404.
29. Nakamura T, Nakamura S, Yokoi T, Ohashi K, Seto M. Clinicopathologic comparison between the API2-MALT1 chimeric transcript-positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res 2002;93:677-84.
30. Okabe M, Inagaki H, Oshima K, Yoshino T, Li C, Eimoto T, et al. API2-MALT1 fusion defines a distinctive clinicopathological subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol 2003;162:1113-22.